Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01068834 · ClinicalTrials.gov registry record
Additional KIF6 Risk Offers Better Adherence to Statins
A clinical trial, sponsored by Medco Health Solutions.
- Completed
- Registry status
- 1,282
- Enrollment target
NCT01068834: Completed study, sponsored by Medco Health Solutions.
NCT01068834 is a clinical trial that has completed, run by Medco Health Solutions. The registered enrollment target is 1,282 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01068834 has completed, sponsored by Medco Health Solutions.
- COMPLETED
- Registry status
- 1,282 participants
- Enrollment target
Study Summary
Many patients prescribed statins to lower their cholesterol stop taking their statin over time. The purpose of this study is to determine whether providing subjects their KIF6 carrier status (associated with increased cardiovascular event risk) will improve adherence to statin medications.
Interventions
- GENETIC KIF6 genetic test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,282 participants |
| Start Date | 2010-03 |
| Est. Completion | 2011-04 |
What the finished NCT01068834 record still lists
NCT01068834 is an observational study that tracks outcomes without assigning an intervention. Its 1,282 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which KIF6 genetic test is the first listed.
NCT01068834 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01068834 about?
NCT01068834 is a clinical study titled "Additional KIF6 Risk Offers Better Adherence to Statins". Many patients prescribed statins to lower their cholesterol stop taking their statin over time. The purpose of this study is to determine whether providing subjects their KIF6 carrier status (associated with increased cardiovascular event risk) will improve adherence to statin medications.
What is the current status of trial NCT01068834?
This trial is currently completed. The enrollment target is 1,282 participants. The study started on 2010-03. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01068834?
The interventions under investigation include: KIF6 genetic test (GENETIC).
Who is sponsoring clinical trial NCT01068834?
This trial is sponsored by Medco Health Solutions, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06626022 · 1,284 participants · Phase 3
Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.
- NCT03970447 · 1,280 participants · Phase 2
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- NCT06468228 · 1,280 participants · Phase 3
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- NCT07207811 · 1,280 participants · Phase 3
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia